m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05725
|
[1] | |||
m6A modification
THRIL
THRIL
METTL14
Methylation
: m6A sites
Direct
Enhancement
Non-coding RNA
THRIL
Regulated Target
lncRNA miRNA circRNA
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 14 (METTL14) | WRITER | |||
| m6A Target | TNF and HNRNPL related immunoregulatory long non-coding RNA (THRIL) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | TNF and HNRNPL related immunoregulatory long non-coding RNA (THRIL) | LncRNA | View Details | ||
| Crosstalk Relationship | m6A → ncRNA | Enhancement | |||
| Crosstalk Mechanism | m6A regulators directly modulate the functionality of ncRNAs through specific targeting ncRNA | ||||
| Crosstalk Summary | LncRNA TNF and HNRNPL related immunoregulatory long non-coding RNA (THRIL), transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells. | ||||
| Responsed Disease | Injury of other or unspecified intrathoracic organs | ICD-11: NB32.3 | |||
| Responsed Drug | LPS | ||||
| Cell Process | mRNA stability | ||||
| Cell autophagy | |||||
In-vitro Model |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
: m6A sites